Eric Lefkofsky Contributes Actively in Precision Medicine

In 2015 Eric Lefkosky co-founded Tempus Labs to help break down the large sets of data available in the health care system. The technology firm runs DNA/RNA sequencing protocols that enable the addition of molecular data. Based in Chicago, Tempus Labs seeks to provide physicians with the information of cancer patients that can be used in developing customized intervention methods.

The firm hopes to take part in precision medicine that is gaining popularity among a lot of medical quarters. Data pipelines were created to have molecular and clinical data collected and analysed. This will enable the consolidation of the patient’s health data. The data gives physicians and health caregivers an opportunity to track the medication given to patients and their responses to the same. Better and more precise treatment options will be offered to the patients.

Its activities have seen Tempus be recognised among the top ten Chicago health techs. It has also partnered with academic institutions as well as health facilities including the Comprehensive Cancer Centers. Most of the patients from the health centers have their genomic material sequenced at Tempus. The results along with the clinical information of the patient are used to create a report that will guide the decision of the healthcare givers. The progress and effective mitigation of cancer mutations can be traced using this method.

Biological markers including brain alterations have recently been used to define Alzheimer’s disease. This is not similar to the symptoms like memory loss that were used in the past. The use of symptoms meant that patients started receiving treatment and special care when the disease was at an advanced stage. The new method will allow for early diagnosis that has great benefits. Brain scans will ensure that the accuracy of the diagnosis and prognosis of the disease are enhanced.

Eric Lefkofsky has made a name for himself among the entrepreneurs of Chicago. He has co-founded numerous firms including Uptake Technologies, Mediaocean, Innerworkings and Lightbank. He supports initiatives to better lives with the Lefkofsky Family Foundation that he co-chairs with his wife Liz.

The Steppenwolf Theatre Company of Chicago appointed him chair of its board of Trustees. He has authored Accelerated Disruption. He has also given generously to philanthropic work including to the Lurie Children’s Hospital.

To know more click: here.

Eric Lefkofsky: Why Harnessing Data Can Change Treatment Mechanisms

Eric Lefkofsky is passionate about using big data to provide alternative solutions. For this reason, he has leverage data to assist in the diagnosis and treatment of cancer. Eric Lefkofsky emphasizes the importance of gathering molecular and clinical data in prognosis. Clinical data collection entails phenotypic information, outcome and therapeutic response while molecular data gives genomic information. Data on the patient, drug history and response and molecular response can help doctors and physicians analyze the risk of treatment, deduce answers for the differences in the response of patients and help in further research.

After experiencing his wife’s battle with breast cancer, Eric realized that data collection and digital technology was not being utilized fully in the healthcare sector. Surprisingly, a lot of data was generated on patient information and treatments but there was no mechanism that allowed the professionals to synchronize and use the data effectively.

The need to make sense of data led to the formation of Tempus, a company that specializes in precision medicine. Erick Lefkofsky is the Chief executive officer and co-founder of the company. The primary objective of Tempus is to revolutionize cancer care. As such, they have created an analytics software that enables outlines and evaluates the clinical and molecular information. The company has had to overcome challenges such as affordability and accessibility of the data at the initial stage. Plus, processing the physician notes that are the primary source of information about the patient’s condition, can be difficult to understand and follow. Nevertheless, the Tempus software allows optical character recognition and processing of natural language. Eric believes that the use of data enabled treatments will increase in future as technology advances. He is hopeful that improvements in genome sequencing will further cancer research and treatment.

Eric Lefkofsky is an alumnus of the University of Michigan. He volunteers on the board of directors of the Art Institute of Chicago and Lurie’s Children’s Memorial Hospital. He lectured at the Kellogg School of Management in Northwestern Univerity and the Depaul University Kellstadt Graduate School of Business. Currently, he is a professor at the Booth School of Business, University of Chicago.

Read More:

Lifeline Screening Provides Peace of Mind for People and Their State of Health

Lifeline Screening provides medical screenings and test to the general public at large without having to be referred of go through a medical procedure to get the test. These tests and screenings are the same as provided through hospitals and medical testing facilities, only in a more convenient and inexpensive way.

People are somewhat reluctant to seek these tests and screenings on their own due to the cost factor and because it is expensive to see a doctor and difficult to get an appointment on short notice. With Lifeline Screening people can get results about their general overall health and if any problems are uncovered their doctor can more readily address the issues.

One important screening test is the limited electrocardiograph screening which shows if a person has atrial fibrillation. This is also called A-Fib for short and if present shows that a person’s heartbeat occurring on an irregular basis. This can be very serious because this condition can cause blood clots to form which can cause a stroke. A person’s doctor should be notified right away if A-Fib is present.

Ultrasound is another very important screening. Ultrasound directs sound waves towards certain organs in the body which shows real-time organ functioning. The ultrasound testing is especially helpful in illustration of blood flow. A test for Carotid artery blood flow shows if any blockage is present and this is important as these are the primary source of blood flow to the brain.

Other ultrasound screens involve testing for osteoporosis by measuring the mineral bone content, abdominal aneurysms, and peripheral artery disease using the ankle-brachial technique.

The finger-stick method of obtaining blood produces a tiny drop or two of blood from which an entire lipid panel can be formed. This will show the cholesterol levels of the HDL and the LDL cholesterol in the blood. From this procedure, a doctor can see what to provide in the way of treatment if these levels are out of line according to proscribed medical protocols.

Glucose screening shows the levels of blood sugar which portray whether or not an individual is pre-diabetic or is a full-blown diabetic. The presence of High-Sensitivity C-reactive protein can indicate the presence of cardiovascular disease to learn more about us: click here.

All of these tests are common in the medical community and are non-invasive. The tests are made available to the individual’s doctor so further analysis and treatment can ensue.